CHICAGO -- Hormone therapy for menopause symptoms reduced insulin resistance in healthy postmenopausal women, a systematic ...

The FDA warned this week that a hormone-free pill for moderate to severe menopausal hot flashes could cause: In their debate ...

Respiratory disease is a leading cause of death for people with certain disabilities, such as SCI or amyotrophic lateral ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window TTHealthWatch is a weekly podcast from Texas Tech. In it, ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Trastuzumab deruxtecan (Enhertu, T-DXd) therapy produced ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding preoperative chemoradiotherapy to perioperative ...

The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker ...

Emergency department nurse Miles Crawford, 39, rescued a man trapped in floodwaters in New Orleans following Hurricane ...

According to Committee Chair Sen. Bernie Sanders (I-Vt.), multiple studies have shown that when private equity firms take ...

"This study reinforces the benefit in vaccinating against mpox with MVA-BN and reaffirms that a single dose provides at least ...

The FDA warned that fezolinetant (Veozah), a hormone-free pill for moderate to severe hot flashes caused by menopause, could ...

Across all studies and doses, females lost up to 24.6% of body weight from baseline whereas men lost a maximum of 18.1% of ...